###begin article-title 0
###xml 27 49 27 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 27 48 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
Interaction of an atypical Plasmodium falciparum ETRAMP with human apolipoproteins
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 85 107 85 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 85 106 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 428 433 <span type="species:ncbi:9606">human</span>
In order to establish a successful infection in the human host, the malaria parasite Plasmodium falciparum must establish interactions with a variety of human proteins on the surface of different cell types, as well as with proteins inside the host cells. To better understand this aspect of malaria pathogenesis, a study was conducted with the goal of identifying interactions between proteins of the parasite and those of its human host.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 166 180 166 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 11 16 <span type="species:ncbi:4932">yeast</span>
###xml 111 116 <span type="species:ncbi:4932">yeast</span>
###xml 166 179 <span type="species:ncbi:5833">P. falciparum</span>
###xml 206 211 <span type="species:ncbi:9606">human</span>
###xml 339 344 <span type="species:ncbi:9606">human</span>
A modified yeast two-hybrid methodology that preferentially selects protein fragments that can be expressed in yeast was used to conduct high-throughput screens with P. falciparum protein fragments against human liver and cerebellum libraries. The resulting dataset was analyzed to exclude interactions that are not likely to occur in the human host during infection.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 316 330 316 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 316 329 <span type="species:ncbi:5833">P. falciparum</span>
###xml 405 410 <span type="species:ncbi:9606">human</span>
An initial set of 2,200 interactions was curated to remove proteins that are unlikely to play a role in pathogenesis based on their annotation or localization, and proteins that behave promiscuously in the two-hybrid assay, resulting in a final dataset of 456 interactions. A cluster that implicates binding between P. falciparum PFE1590w/ETRAMP5, a putative parasitophorous vacuole membrane protein, and human apolipoproteins ApoA, ApoB and ApoE was selected for further analysis. Different isoforms of ApoE, which are associated with different outcomes of malaria infection, were shown to display differential interactions with PFE1590w.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 46 60 46 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 139 153 139 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 46 59 <span type="species:ncbi:5833">P. falciparum</span>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 139 152 <span type="species:ncbi:5833">P. falciparum</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
A dataset of interactions between proteins of P. falciparum and those of its human host was generated. The preferential interaction of the P. falciparum PFE1590w protein with the human ApoE epsilon3 and ApoE epsilon4 isoforms, but not the ApoE epsilon2 isoform, supports the hypothesis that ApoE genotype affects risk of malaria infection. The dataset contains other interactions of potential relevance to disease that may identify possible vaccine candidates and drug targets.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 177 198 177 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 922 923 922 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 177 198 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 894 899 <span type="species:ncbi:9606">human</span>
Malaria is a devastating global disease, responsible for approximately 500 million clinical cases and more than a million deaths per year [1]. The most deadly form is caused by Plasmodium falciparum, which has a complex life cycle. The parasite is delivered to the human bloodstream as sporozoites that develop in the salivary gland of infected mosquitoes. These motile forms enter the liver, transversing through several cells before establishing themselves in a hepatocyte. Within the hepatocyte, the parasite undergoes a large number of asexual divisions, eventually releasing tens of thousands of merozoites that are capable of attaching to and invading erythrocytes. Within the erythrocyte, the parasite again divides several times in a 48-hour timeframe, releasing 16 or more merozoites that invade new erythrocytes. This intraerythrocytic stage is responsible for the cyclic symptoms of human disease (reviewed in [2]).
###end p 11
###begin p 12
###xml 36 50 36 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 397 411 397 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 467 481 467 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 821 822 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 823 824 823 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 36 49 <span type="species:ncbi:5833">P. falciparum</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 397 410 <span type="species:ncbi:5833">P. falciparum</span>
###xml 467 480 <span type="species:ncbi:5833">P. falciparum</span>
###xml 557 562 <span type="species:ncbi:9606">human</span>
As a consequence of its life cycle, P. falciparum must be able to recognize, bind to and invade at least the two human cell types of hepatocytes and erythrocytes. These events are defined by particular molecular interactions. For example, hepatocyte invasion requires binding of the parasite's circumsporozoite surface protein to heparan sulfate proteoglycan surface receptors [3], although other P. falciparum proteins have been implicated in this process [4]. Many P. falciparum proteins have been proposed to be involved in erythrocyte invasion, and the human receptors for a few of them have been characterized (for example, EBA-175/glycophorin A and EBA-140/glycophorin C, MSP1/band3); however, the receptors for most of the parasite proteins implicated in erythrocyte invasion remain to be identified (reviewed in [5,6]).
###end p 12
###begin p 13
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 345 359 345 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1025 1026 1025 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1077 1079 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1080 1082 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 345 358 <span type="species:ncbi:5833">P. falciparum</span>
###xml 941 946 <span type="species:ncbi:9606">human</span>
In both hepatocytes and erythrocytes, the parasite is contained in a membranous structure known as the parasitophorous vacuole. Within this structure, however, the parasite is not isolated from the host cell, and must import nutrients from the plasma and the host cell cytoplasm to survive [7]. Particularly in the case of erythrocyte invasion, P. falciparum also establishes an active export of its proteins to the cytoplasm and surface of the host cell, where they modify the surface's structural and adhesive properties (reviewed in [8]). The presence of parasite proteins, such as PfEMP1 and other adhesins on the surface of erythrocytes, causes these infected cells to sequester to endothelia and placenta via interactions with surface receptor molecules such as CD36, chondroitin sulfate A, ICAM-1 and selectins, resulting in the evasion of these cells from the host immune system. In addition, several parasite proteins interact with human cytoskeletal proteins; for example, PfEMP3 interacts with spectrin and actin [9], and both RESA and KAHRP interact with spectrin [10,11].
###end p 13
###begin p 14
###xml 66 80 66 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 219 233 219 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 543 557 543 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 66 79 <span type="species:ncbi:5833">P. falciparum</span>
###xml 141 146 <span type="species:ncbi:4932">yeast</span>
###xml 219 232 <span type="species:ncbi:5833">P. falciparum</span>
###xml 250 255 <span type="species:ncbi:9606">human</span>
###xml 543 556 <span type="species:ncbi:5833">P. falciparum</span>
###xml 578 583 <span type="species:ncbi:9606">human</span>
Previously, a large network of interactions among the proteins of P. falciparum was generated [12]. The results of a similar high-throughput yeast two-hybrid analysis aimed at detecting interactions between proteins of P. falciparum and those of its human host are presented here. An initial dataset of over 2,200 putative interactions was curated to exclude interactions that are not likely to be relevant to the pathogenesis of the parasite, resulting in a final dataset of 456 interactions. Among these, a cluster of interactions involving P. falciparum PFE1590w/ETRAMP5 and human apolipoproteins ApoA1, ApoB and ApoE was studied further.
###end p 14
###begin title 15
Materials and methods
###end title 15
###begin title 16
###xml 41 46 <span type="species:ncbi:4932">yeast</span>
Library construction and high-throughput yeast two hybrid screens
###end title 16
###begin p 17
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 81 95 81 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 81 94 <span type="species:ncbi:5833">P. falciparum</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 204 209 <span type="species:ncbi:4932">yeast</span>
###xml 227 232 <span type="species:ncbi:4932">yeast</span>
Protocols described in [12] were used to generate libraries of plasmids encoding P. falciparum and human protein fragments as fusions with Gal4 domains and auxotrophic markers to select for expression in yeast. High-throughput yeast two-hybrid screens, selection of positive colonies, PCR amplification and sequencing of inserts to determine the identity of the interacting partners were also performed following the techniques described in [12].
###end p 17
###begin title 18
Dataset curation and filtering
###end title 18
###begin p 19
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 385 399 385 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
###xml 385 398 <span type="species:ncbi:5833">P. falciparum</span>
Plasmodium falciparum protein annotations were downloaded from PlasmoDB [13] and human protein annotations were downloaded from DAVID [14]. Information was also obtained from other databases, including GeneCards [15], Entrez Gene [16] and GeneDB [17]. K-clustering was performed as described in [12] and resulted in the exclusion of human proteins with 25 or more partners (k = 2) and P. falciparum proteins with 18 or more partners (k = 3).
###end p 19
###begin title 20
Two-hybrid retests
###end title 20
###begin p 21
###xml 190 204 190 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 242 267 242 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 394 408 394 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae </italic>
###xml 459 468 459 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 643 648 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3 </italic>
###xml 49 54 <span type="species:ncbi:4932">yeast</span>
###xml 141 146 <span type="species:ncbi:4932">yeast</span>
###xml 155 160 <span type="species:ncbi:4932">yeast</span>
###xml 190 203 <span type="species:ncbi:5833">P. falciparum</span>
###xml 242 266 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 325 330 <span type="species:ncbi:4932">yeast</span>
###xml 350 355 <span type="species:ncbi:9606">human</span>
###xml 394 407 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 459 467 <span type="species:ncbi:4896">S. pombe</span>
Plasmids were purified from the positive diploid yeast strains identified in the high-throughput screens, sequenced, and re-transformed into yeast. R2HMet yeast strains expressing different P. falciparum protein fragments as fusions with the Saccharomyces cerevisiae Gal4 DNA-binding domain and Met2 were mated against BK100 yeast strains expressing human protein fragments as fusions with the S. cerevisiae Gal4 activation domain and Ura3 (or its orthologue S. pombe Ura4) [12]. For retesting positives, diploids were selected in synthetic media lacking tryptophan and leucine with or without extra adenine, and their ability to activate the HIS3 reporter gene in the presence of 0 to 3 mM 3-aminotriazole was tested by streaking or serial dilution. Plates were grown at 30degreesC for up to a week and scanned.
###end p 21
###begin title 22
Protein extracts and western blots
###end title 22
###begin p 23
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast extracts were prepared as described [18] and subjected to electrophoresis on 4-12% NuPAGE/MOPS gels (Invitrogen). Western blotting was performed using standard procedures with 1:100 dilution of anti-GAL4-TA (C-10) antibodies (Santa Cruz) and 1:5,000 dilution of anti-actin antibodies.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
Filtering of a high throughput two-hybrid dataset
###end title 25
###begin p 26
###xml 33 47 33 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 291 305 291 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 429 443 429 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 642 656 642 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 917 931 917 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 33 46 <span type="species:ncbi:5833">P. falciparum</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 78 83 <span type="species:ncbi:4932">yeast</span>
###xml 253 258 <span type="species:ncbi:4932">yeast</span>
###xml 291 304 <span type="species:ncbi:5833">P. falciparum</span>
###xml 429 442 <span type="species:ncbi:5833">P. falciparum</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
###xml 642 655 <span type="species:ncbi:5833">P. falciparum</span>
###xml 692 697 <span type="species:ncbi:9606">human</span>
###xml 735 740 <span type="species:ncbi:4932">yeast</span>
###xml 917 930 <span type="species:ncbi:5833">P. falciparum</span>
###xml 939 944 <span type="species:ncbi:9606">human</span>
To identify interactions between P. falciparum and human proteins, a modified yeast two-hybrid approach was applied as described previously [12]. This method preferentially selects for plasmids that encode fragments of proteins that can be expressed in yeast, and is particularly useful for P. falciparum proteins, which are difficult to express in heterologous systems. DNA-binding domain (BD) libraries of protein inserts from P. falciparum mRNA expressed during the intraerythrocytic cycle and activation domain (AD) libraries from human liver and cerebellum mRNA were generated. 9,408 two-hybrid screens with randomly chosen fragments of P. falciparum proteins were performed against the human activation domain libraries. Diploid yeast strains were selected and the identities of the putative interactive partners were determined as described [12]. These searches yielded 2,212 unique interactions involving 507 P. falciparum and 986 human proteins.
###end p 26
###begin p 27
###xml 119 129 119 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 160 165 <span type="species:ncbi:9606">human</span>
###xml 346 351 <span type="species:ncbi:4932">yeast</span>
As with other high throughput two-hybrid studies, many of the putative interactions identified likely do not represent bona fide binding between a parasite and human protein but correspond instead to false positives that arise in these assays [19]. The bulk of these false positives are due to proteins that lead to transcriptional activation in yeast in the absence of any interaction between the proteins encoded by the two-hybrid vectors. Such proteins can be identified by a variety of means, including their over-representation among the putative interactions.
###end p 27
###begin p 28
###xml 113 121 113 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 250 264 250 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 428 442 428 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 77 82 <span type="species:ncbi:4932">yeast</span>
###xml 250 263 <span type="species:ncbi:5833">P. falciparum</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 380 385 <span type="species:ncbi:9606">human</span>
###xml 428 441 <span type="species:ncbi:5833">P. falciparum</span>
###xml 466 471 <span type="species:ncbi:9606">human</span>
In other cases, the two-hybrid results reflect proteins that interact in the yeast assay but not in their normal in vivo setting. For example, the initial dataset contained examples of putative interactions between two orthologous proteins, one from P. falciparum and one from human, indicating most likely that each of these proteins normally homodimerizes. In other examples, a human protein was observed to interact with the P. falciparum orthologue of its known human protein partner. Both of these types of interactions reflect the high degree of conservation of these protein pairs between the two species.
###end p 28
###begin p 29
###xml 43 57 43 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 544 558 544 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 888 902 888 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1232 1246 1232 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 43 56 <span type="species:ncbi:5833">P. falciparum</span>
###xml 544 557 <span type="species:ncbi:5833">P. falciparum</span>
###xml 888 901 <span type="species:ncbi:5833">P. falciparum</span>
###xml 905 910 <span type="species:ncbi:9606">human</span>
###xml 1232 1245 <span type="species:ncbi:5833">P. falciparum</span>
Interactions more likely to be relevant to P. falciparum pathogenesis were identified by curation of the initial dataset, taking into account available information about the proteins involved in the interactions. Annotated and predicted GO classifications were considered, as well as other functions and properties of the proteins: the presence of transmembrane domains, evidence of membrane localization (except for nuclear membrane localization), and classification as extracellular or secreted protein were considered positive features. For P. falciparum proteins, the presence of a signal peptide, evidence or prediction of export to the host cell cytoplasm, presence in Maurer's clefts, localization to the surface of the infected erythrocyte, and classification as a putative adhesin were also considered as positive features (see PlasmoDB for data sources). Interactions involving P. falciparum or human proteins with likely nuclear function, mitochondrial localization, roles in basic cellular processes (including translation, RNA processing, protein degradation, ubiquitin metabolism and nuclear/cytoplasmic transport), and metabolic enzymes were excluded from the final dataset. Also excluded were interactions involving P. falciparum proteins annotated as chaperones, apicoplast or cytoskeleton proteins, if there was no additional evidence of their being exported to the host cell.
###end p 29
###begin p 30
###xml 133 143 133 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 621 635 621 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 593 598 <span type="species:ncbi:4932">yeast</span>
###xml 621 634 <span type="species:ncbi:5833">P. falciparum</span>
###xml 652 657 <span type="species:ncbi:9606">human</span>
In addition, a large number of apparent partners that likely activate the two-hybrid reporter gene by mechanisms that do not involve bona fide interactions were eliminated by a k-clustering algorithm that takes into consideration the number of partners of each protein in the dataset to establish thresholds for exclusion. By this means, all proteins present as DNA-binding domain fusions with 18 or more interactions and as activation domain fusions with 25 or more interactions were excluded. Putative interactions of proteins that had been classified as promiscuous in previous large-scale yeast two-hybrid studies of P. falciparum proteins [12] or human proteins (unpublished data from Prolexys Pharmaceuticals, Inc.) were also excluded.
###end p 30
###begin p 31
###xml 224 238 224 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 224 237 <span type="species:ncbi:5833">P. falciparum</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
Although these filters potentially exclude some biologically relevant interactions, the majority of the interactions removed are most likely false positives. The resulting dataset consists of 456 interactions, involving 203 P. falciparum proteins and 314 human proteins (Additional file 1), and is enriched for proteins that are likely to be at the interface of the parasite and the host.
###end p 31
###begin title 32
###xml 15 29 15 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 15 28 <span type="species:ncbi:5833">P. falciparum</span>
###xml 43 48 <span type="species:ncbi:9606">human</span>
Interaction of P. falciparum PFE1590w with human apolipoproteins
###end title 32
###begin p 33
###xml 34 48 34 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 969 971 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 34 47 <span type="species:ncbi:5833">P. falciparum</span>
###xml 82 87 <span type="species:ncbi:9606">human</span>
###xml 160 165 <span type="species:ncbi:9606">human</span>
A cluster of interactions between P. falciparum hypothetical protein PFE1590w and human apolipoproteins ApoA1, ApoB and ApoE was identified from screens of the human liver cDNA library (Additional file 1). PFE1590w (alternatively known as etrampBLOB.1, ETRAMP5 and antigen 22) is a protein of unknown function that belongs to the ETRAMP (Early TRAnscribed Membrane Proteins) or SEP (Small Exported Proteins) family of single-pass transmembrane proteins [20,21]. Several ETRAMPs have been shown to localize to the parasitophorous vacuole, the membranous structure in which the parasite resides when inside the erythrocyte and hepatocyte [21]. A transfected myc-tagged version of PFE1590w localizes to the periphery of late ring and early trophozoite-infected erythrocytes, suggesting that, like other ETRAMPs, the native PFE1590w could also be localized to the parasitophorous vacuole membrane, where it would be at the interface between the parasite and the host cell [22]. Apolipoproteins are expressed by the liver and intestine and secreted to the plasma, where they bind cholesterol and participate in the clearance of lipoprotein particles by hepatocytes [23].
###end p 33
###begin p 34
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
Four overlapping fragments of PFE1590w interacted with 15 overlapping ApoA1 fragments, 1 ApoE fragment and 3 ApoB fragments (Figure 1A). All of the PFE1590w fragments contained the transmembrane domain and extended to different extents towards the amino- and carboxy-termini, including variable amounts of the region of highest amino acid complexity in the PFE1590w protein. ApoA and ApoE belong to the same family and share sequence and structural features, as well as common receptors on the surface of the hepatocytes [23]. Alignment of the fragments of ApoA and ApoE that interacted with PFE1590w revealed a conserved region that could be responsible for this interaction (Figure 1B).
###end p 34
###begin p 35
###xml 21 35 21 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Interactions between <italic>P. falciparum </italic>PFE1590w and human apolipoproteins ApoA, ApoE and ApoB identified by high-throughput screens</bold>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 21 34 <span type="species:ncbi:5833">P. falciparum</span>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 405 410 <span type="species:ncbi:9606">human</span>
Interactions between P. falciparum PFE1590w and human apolipoproteins ApoA, ApoE and ApoB identified by high-throughput screens. (A) The fragments of PFE1590w involved in the interactions with human apolipoproteins are depicted above a diagram of the full-length protein, with the amino-terminal signal peptide (SP) and the transmembrane domain (TM) indicated. Low complexity regions are shown below. The human apolipoproteins that interacted with each PFE1590w peptide are listed to the right. The domain predicted by Phobius [30] to be exposed to the cytoplasm is shown. Numbers correspond to amino acid coordinates. (B) The fragments of ApoA1 and ApoE involved in the interactions were aligned by the MAVID/AMAP multiple alignment server [48]. The box indicates the region conserved among all ApoA1 and ApoE protein fragments identified in the screens.
###end p 35
###begin p 36
###xml 698 699 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 74 79 <span type="species:ncbi:4932">yeast</span>
###xml 539 544 <span type="species:ncbi:4932">yeast</span>
Plasmids encoding PFE1590w or apolipoprotein fragments were purified from yeast transformants and resequenced to determine both the exact starting and ending residues of the inserts as well as the reading frame with respect to the Gal4 DNA-binding or activation domain. Three of the PFE1590w fragments (excluding one that was highly similar to one of these three) were retested against nine different apolipoprotein fragments (all the ApoB and ApoE fragments, and five representative ApoA1 fragments) by introducing plasmids back into the yeast strains and repeating the mating and selection procedures in small scale. This assay confirmed binding between PFE1590w and ApoA1, ApoE and ApoB (Figure 2). The interactions were specific, as demonstrated by the lack of growth under selective conditions of strains carrying PFE1590w or an apolipoprotein insert along with an empty two-hybrid vector or one encoding for an unrelated fusion protein.
###end p 36
###begin p 37
###xml 39 53 39 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 0 121 0 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Reproducibility and specificity of the <italic>P. falciparum </italic>PFE1590w interactions with human apolipoproteins ApoA, ApoE and ApoB</bold>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3 </italic>
###xml 379 393 379 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 651 665 651 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 39 52 <span type="species:ncbi:5833">P. falciparum</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 379 392 <span type="species:ncbi:5833">P. falciparum</span>
###xml 397 402 <span type="species:ncbi:9606">human</span>
###xml 651 664 <span type="species:ncbi:5833">P. falciparum</span>
Reproducibility and specificity of the P. falciparum PFE1590w interactions with human apolipoproteins ApoA, ApoE and ApoB. Diploid strains expressing different combinations of PFE1590w and human apolipoprotein fragments as fusion proteins were tested for their ability to activate the HIS3 reporter gene in the presence of 3 mM 3-aminotriazole. The amino acid coordinates of the P. falciparum and human interacting protein fragments are indicated. Controls are strains carrying empty vectors encoding Gal4 BD or Gal4 AD, as well as fusions of Gal4 BD-PFE1350c (amino acids 9 to 135) and Gal4 AD-PFC0255c (amino acids 4 to 136), an interacting pair of P. falciparum proteins [12].
###end p 37
###begin p 38
###xml 338 340 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 477 479 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 575 577 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 578 580 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 659 673 641 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 901 915 865 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae </italic>
###xml 1064 1066 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1074 1079 1038 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MET2 </italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 659 672 <span type="species:ncbi:5833">P. falciparum</span>
###xml 901 914 <span type="species:ncbi:4932">S. cerevisiae</span>
The gene for apolipoprotein ApoE is present in human populations as three alleles that differ only by the amino acid residue encoded in positions 112 and 158: ApoE epsilon2 contains cysteine in both positions, ApoE epsilon3 contains cysteine in position 112 but arginine in position 158, and ApoE epsilon4 has arginine in both positions [24]. These changes have been associated with differences in the structure of the protein, and in turn, their function in lipid metabolism [23]. Because the different ApoE alleles have been implicated in the outcome of malaria infection [25-27], the selectivity of interactions between the corresponding ApoE isoforms and P. falciparum PFE1590w was studied. To this end, full-length versions of the three alleles of ApoE (ApoE epsilon2, epsilon3, and epsilon4) were cloned into the Gal4 AD vector. To ensure that the interactions did not depend on the presence of S. cerevisiae Met2 on the carboxy-terminus of the PFE1590w fusion protein (which is used to select for expressed proteins in this version of the two-hybrid assay [12]), the MET2 coding sequence was replaced with that for glutathione S-transferase (GST). This construct yielded a stronger growth signal in the presence of the AD-apolipoprotein hybrids than the original one, and was, therefore, used for all further experiments.
###end p 38
###begin p 39
###xml 238 240 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 509 511 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 8 13 <span type="species:ncbi:4932">yeast</span>
###xml 278 283 <span type="species:ncbi:4932">yeast</span>
Diploid yeast containing BD-PFE1590w (amino acids 94-156)-GST and an AD hybrid containing either of the two isoforms of the ApoE protein with arginine at position 158 (ApoE epsilon3 and ApoE epsilon4) grew well on selective media (Figure 3A, right panel). In contrast, when the yeast contained instead the ApoE epsilon2 isoform with cysteine at position 158, much weaker growth was observed. All transformants exhibited comparable growth on media that does not select for protein-protein interactions (Figure 3A, left panel). The ApoE selectivity is consistent with the results from the high-throughput screens that identified an ApoE fragment extending from residue 139 to 309 with arginine in position 158, corresponding to either the Apo epsilon3 or the epsilon4 isoform.
###end p 39
###begin p 40
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 0 98 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>P. falciparum </italic>PFE1590w interacts differentially with ApoE isoforms &#949;2, &#949;3 and &#949;4</bold>
###xml 172 176 154 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">660 </sub>
###xml 503 507 485 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink">660 </sub>
###xml 0 13 <span type="species:ncbi:5833">P. falciparum</span>
###xml 104 109 <span type="species:ncbi:4932">Yeast</span>
###xml 457 462 <span type="species:ncbi:4932">yeast</span>
P. falciparum PFE1590w interacts differentially with ApoE isoforms epsilon2, epsilon3 and epsilon4. (A) Yeast diploids containing the indicated plasmids were grown to an OD660 = 1.0, serially diluted and spotted onto solid synthetic complete media missing tryptophan and leucine and supplemented with extra adenine (SC-T-L+Ade), and onto plates missing tryptophan, leucine and histidine, and incubated at 30 C for 5-7 days. (B) Proteins were extracted from yeast cells grown in SC-T-L+Ade media to an OD660 = 1.0, separated by gel electrophoresis and transferred onto membranes by Western blot. Fusion proteins were detected with antibodies directed towards the Gal4 activation domain (upper panel), and antibodies against actin were used as a loading control (bottom panel).
###end p 40
###begin p 41
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 133 138 <span type="species:ncbi:4932">yeast</span>
To rule out the possibility that differential two-hybrid signals could result from variable expression of the three ApoE isoforms in yeast, the levels of ApoE proteins were assayed by Western blot. Comparable expression of the three ApoE isoforms as AD hybrid proteins was observed (Figure 3B, top panel), with actin expression serving as a loading control (Figure 3B, bottom panel). Thus, these data indicate that the interaction of PFE1590w with ApoE proteins is dependent on the presence of arginine at position 158 of the ApoE protein. Polymorphisms at this position also influence the ability of ApoE to interact with other molecules, such as lipids and the LDL receptor [23].
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 239 252 239 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 688 698 688 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 191 196 <span type="species:ncbi:9606">human</span>
###xml 222 252 <span type="species:ncbi:5833">malaria parasite P. falciparum</span>
###xml 546 551 <span type="species:ncbi:4932">yeast</span>
Protein-protein interactions underlie the critical processes of infectious diseases, determining the specificity, affinity and efficiency by which pathogenic organisms are able to invade the human host. In the case of the malaria parasite P. falciparum, several processes that are essential to pathogenesis depend on host-parasite interactions, such as entry into host cells, growth and division within these cells, and binding to the lining of vasculature. An effort to identify such interactions was undertaken through the use of a large-scale yeast two-hybrid screening approach. The initial dataset of putative interactions was pared down to 456 interactions deemed most likely to be bona fide ones. However, two-hybrid false positives remain in this pared down set and no complementary verification of these interactions by a biochemical approach, such as co-immunoprecipitation, has been carried out; thus, these interaction data should be interpreted cautiously.
###end p 43
###begin p 44
###xml 25 39 25 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 25 38 <span type="species:ncbi:5833">P. falciparum</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 170 175 <span type="species:ncbi:4932">yeast</span>
The interactions between P. falciparum hypothetical protein PFE1590w and human apolipoproteins ApoA1, ApoB and ApoE were further studied and determined to be specific by yeast two-hybrid. Furthermore, the preferential interaction of PFE1590w with the ApoE epsilon3 and ApoE epsilon4 isoforms but not the ApoE epsilon2 isoform was observed.
###end p 44
###begin p 45
###xml 14 28 14 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 206 217 206 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 291 302 291 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 14 27 <span type="species:ncbi:5833">P. falciparum</span>
The genome of P. falciparum encodes 13 members of the ETRAMP protein family, which are predicted to have an amino-terminal signal peptide and a single transmembrane domain [21]. ETRAMPs are conserved among Plasmodium species, although PFE1590w does not have a clear orthologue in the rodent Plasmodium species. Unlike other ETRAMPs, PFE1590w is abundant in negatively charged residues, and has a 50-residue insertion rich in serines and prolines between the signal peptide and the transmembrane domain, resulting in its annotation as an atypical ETRAMP [21]. The gene encoding PFE1590w is expressed during the intraerythrocytic cycle [21,28,29] as well as in liver stages (Cate Speake and Patrick Duffy, personal communication). A transfected myc-tagged version of PFE1590w localizes to the periphery of the parasite in late ring and early trophozoite-infected erythrocytes, suggesting a parasitophorous vacuole membrane localization for this protein inside the infected erythrocytes [22]. Phobius [30], a programme that predicts the orientation of membrane proteins, predicts that residues 136-181 are cytoplasmic (Figure 1A), suggesting that the carboxy-terminal domain involved in the interactions described in this study could be exposed to the cytoplasm of the host cell. Since apolipoprotein-containing particles are internalized by the hepatocyte [23], if PFE1590w also localizes to the parasitophorous vacuole during the liver stages, the interactions between PFE1590w and apolipoproteins could take place in the hepatocyte.
###end p 45
###begin p 46
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
The mRNA for PFE1590w has also been detected in gametocytes and in sporozoites [21,29], and PFE1590w peptides have been detected by mass spectrometry in trophozoites and in the membrane of the infected erythrocytes [31,32]. Parasite inhibitory antibodies against PFE1590w are present in the sera of individuals that have suffered malaria infections, supporting the idea that PFE1590w might be a surface protein, although it is also possible that this immunity is a result of exposure of the immune system of the host to the protein upon lysis of the parasite [33]. Therefore, besides being localized to the parasitophorous vacuole membrane, PFE1590w could be present on the plasma membrane of the sporozoite or the membrane of the infected red blood cell, where it could interact with plasma apolipoproteins.
###end p 46
###begin p 47
###xml 81 99 81 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium yoelii </italic>
###xml 199 213 199 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 696 710 696 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 81 98 <span type="species:ncbi:5861">Plasmodium yoelii</span>
###xml 199 212 <span type="species:ncbi:5833">P. falciparum</span>
###xml 679 684 <span type="species:ncbi:9606">human</span>
###xml 696 709 <span type="species:ncbi:5833">P. falciparum</span>
Other ETRAMPs have been shown to be involved in interactions with host proteins. Plasmodium yoelii UIS3, a rodent ETRAMP essential for parasite development during liver stages that is orthologous to P. falciparum PF13_0012, interacts with liver fatty-acid binding protein (L-FABP) [34]. UIS3 localizes to the parasitophorous vacuole membrane within the hepatocyte [35], and binds L-FABP via its carboxy-terminal domain, which is predicted to be exposed to the cytoplasm of the host cell cytoplasm. Down-regulation of L-FABP by RNAi greatly inhibits the growth of parasites in cultured hepatoma cells, whereas overexpression of L-FABP promotes growth [34]. An interaction between human L-FABP and P. falciparum PFD0090c was observed in this study. PFD0090c is a hypothetical protein of the pHIST family[36], and is predicted to be exported to the cytoplasm of the host cell. In addition, PFD0090c has also been found by mass spectrometry on the surface of the infected erythrocyte [31].
###end p 47
###begin p 48
###xml 198 209 198 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 582 593 579 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 602 612 599 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei</italic>
###xml 737 744 734 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 745 747 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1419 1421 1404 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1422 1424 1407 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1548 1550 1527 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1710 1712 1677 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1877 1879 1844 1846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 602 612 <span type="species:ncbi:5821">P. berghei</span>
###xml 618 622 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1035 1040 <span type="species:ncbi:9606">human</span>
###xml 1125 1130 <span type="species:ncbi:9606">human</span>
###xml 1448 1456 <span type="species:ncbi:9606">children</span>
###xml 1787 1795 <span type="species:ncbi:9606">children</span>
###xml 1989 1994 <span type="species:ncbi:9606">human</span>
Several lines of evidence suggest that apolipoproteins might have a role in the pathogenesis of the malaria parasite. First, apolipoproteins have been reported to inhibit invasion of hepatocytes by Plasmodium sporozoites by competing with the most abundant protein on the surface of sporozoites, circumsporozoite protein, for binding to HepG2 cultured liver cells, and delaying liver-mediated clearance of circumsporozoite protein from circulation [37]. Second, apolipoprotein E-enriched beta-very low density lipoprotein inhibits invasion of HepG2 cells by sporozoites of a rodent Plasmodium species, P. berghei, and mice with high levels of circulating apolipoproteins have lower hepatic parasite loads. Based on this evidence, Sinnis et al. [37] postulated that invasion of hepatocytes by the parasite and lipoprotein uptake by the liver share a common mechanism that is likely mediated by binding to heparan sulfate proteoglycans, the physiological receptors of apolipoproteins on the surface of the hepatocytes. Third, studies of human populations have revealed correlations between the apolipoprotein E genotype of the human host and the susceptibility to malaria infection; although the ApoE epsilon3 allele is the most frequent worldwide, the ApoE epsilon4 allele, which is possibly the ancestral one, has an extremely high frequency in malaria endemic areas, including sub-Saharan Africa and Papua New Guinea [38,39]. In addition, Gambian children homozygous for the ApoE epsilon2 allele are more likely to suffer early malaria infection [25], while heterozygotes carrying the ApoE epsilon3 and epsilon4 alleles are more likely to suffer severe malaria, including cerebral malaria and severe anaemia [26]. These apparently contradictory data are compatible with the notion that children who suffer infections earlier in life develop protection against severe malaria [27]. While these results are based on a small number of individuals, they suggest that the ApoE genotype of the human host influences the outcome of malaria infection. The data presented here that indicates a selective interaction between PFE1590w and ApoE alleles epsilon3 and epsilon4 is consistent with the notion that this interaction might be related to malaria pathogenesis. It is possible that the PFE1590w - ApoE interaction is important for cerebral malaria and severe anaemia, and thus individuals carrying ApoE epsilon3 and epsilon4 alleles are more likely to develop these symptoms.
###end p 48
###begin p 49
###xml 477 487 477 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. yoelii </italic>
###xml 608 625 608 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Toxoplasma gondii</italic>
###xml 663 676 663 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 962 972 962 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii </italic>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1092 1106 1092 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 1110 1128 1110 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Toxoplasma gondii </italic>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 477 486 <span type="species:ncbi:5861">P. yoelii</span>
###xml 608 625 <span type="species:ncbi:5811">Toxoplasma gondii</span>
###xml 663 676 <span type="species:ncbi:5833">P. falciparum</span>
###xml 962 971 <span type="species:ncbi:5811">T. gondii</span>
###xml 1092 1105 <span type="species:ncbi:5833">P. falciparum</span>
###xml 1110 1127 <span type="species:ncbi:5811">Toxoplasma gondii</span>
The relevance of the PFE1590w - apolipoprotein interaction for the parasite's ability to infect or develop within human host cells remains to be determined. Apolipoproteins are synthesized in the liver, and are cleared from circulation by the liver. The interaction may be involved in the invasion of liver cells by sporozoites, or alternatively, the interaction could be important for the parasite's survival inside the red blood cell or the hepatocyte. As in the case of the P. yoelii UIS3 - L-FABP interaction, PFE1590w might be involved in the uptake of lipids, in particular cholesterol, from the host. Toxoplasma gondii, an apicomplexan parasite related to P. falciparum, critically depends on host cholesterol from low-density plasma lipoproteins for survival, which it acquires by co-opting the host endocytosis pathway and sequestering lysosomes into its parasitophorous vacuole [40-42]. Although the proteins responsible for cholesterol acquisition in T. gondii have not been identified, it is likely that they are also localized to the parasitophorous membrane [40-42]. Thus, both P. falciparum and Toxoplasma gondii might have similar mechanisms of nutrient acquisition from the host cell.
###end p 49
###begin p 50
###xml 27 41 27 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 260 274 260 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1230 1232 1230 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 27 40 <span type="species:ncbi:5833">P. falciparum</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 260 273 <span type="species:ncbi:5833">P. falciparum</span>
###xml 321 326 <span type="species:ncbi:9606">human</span>
###xml 473 478 <span type="species:ncbi:4932">yeast</span>
###xml 961 966 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Other interactions between P. falciparum and human proteins that may shed light on parasite invasion and other processes were identified in this study. For example, in a screen against the liver human library, an interaction was observed between a fragment of P. falciparum EXP-1 (PF11_0224) and overlapping fragments of human Programmed Cell Death 6-Interacting protein (PDCD6IP, or ALIX) (Additional file 1). This interaction was shown to be reproducible and specific by yeast two-hybrid (data not shown). EXP-1 is a well-characterized integral membrane protein localized to the parasitophorous vacuole [43,44]. PDCD6IP/ALIX is a class E vacuolar sorting protein involved in the transport of cargo proteins by the multivesicular body for incorporation into intralumenal vesicles; fusion between endosomes and the vacuole results in the localization of cargo proteins to the vacuolar lumen [45]. In addition, PDCD6IP/ALIX is used by several viruses, including HIV-1, for exiting infected cells [46]. Although the interaction was identified in the high-throughput screens against the liver library, EXP-1 is also expressed in blood stages, and PDCD6IP/ALIX has been found by mass spectrometry in the cytoplasm of the erythrocyte [47], suggesting that the interaction could take place in either the hepatocyte or the erythrocyte. It is possible that this interaction is involved in acquisition of vesicle contents by the parasite.
###end p 50
###begin title 51
Conclusion
###end title 51
###begin p 52
###xml 44 58 44 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 204 218 204 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 44 57 <span type="species:ncbi:5833">P. falciparum</span>
###xml 117 122 <span type="species:ncbi:9606">human</span>
###xml 204 217 <span type="species:ncbi:5833">P. falciparum</span>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 606 611 <span type="species:ncbi:9606">human</span>
More than 450 putative interactions between P. falciparum proteins expressed during the intra-erythrocytic cycle and human proteins expressed in liver or cerebellum are presented. The interaction between P. falciparum PFE1590w, an ETRAMP, and human apolipoproteins was further studied, and a differential interaction between PFE1590w and isoforms of ApoE that have been associated with different outcomes of malaria infection was observed. It is likely that this dataset will include other interactions of potential interest that will expand the understanding of the interplay between the parasite and the human host and may lead to the identification of potential vaccine candidates and drug targets.
###end p 52
###begin title 53
Competing interests
###end title 53
###begin p 54
The authors declare that they have no competing interests.
###end p 54
###begin title 55
Authors' contributions
###end title 55
###begin p 56
###xml 41 55 41 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 235 249 235 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 41 54 <span type="species:ncbi:5833">P. falciparum</span>
###xml 235 248 <span type="species:ncbi:5833">P. falciparum</span>
MV participated in the generation of the P. falciparum Y2H libraries and data analysis and curation, and drafted the manuscript. AM retested the interactions and carried out the Western blots. DJL participated in the generation of the P. falciparum Y2H libraries and data analysis. RC and RB managed the database of interactions. REH, SS and SF conceived the study and participated in its coordination. All authors read and approved the final manuscript.
###end p 56
###begin title 57
Supplementary Material
###end title 57
###begin title 58
Additional file 1
###end title 58
###begin p 59
###xml 48 70 48 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 48 69 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
Curated list of interactions identified between Plasmodium falciparum and human protein fragments.
###end p 59
###begin p 60
Click here for file
###end p 60
###begin title 61
Acknowledgements
###end title 61
###begin p 62
This work was supported in part by grant P50 GM64655 from the NIH. S.F. is an investigator of the Howard Hughes Medical Institute. We thank S. Mikolajczak, X. Peng and S. Kappe for their analysis of interactions generated by screening the liver library, Cate Speake and Patrick Duffy for sharing data demonstrating the expression of PFE1590w in asexual blood and liver stages by qPCR, and Wonjong Moon and in particular Jingyang Chen for help with compiling protein information for Additional file 1.
###end p 62
###begin article-title 63
The Malaria Atlas Project: Developing Global Maps of Malaria Risk
###end article-title 63
###begin article-title 64
Malaria - an overview
###end article-title 64
###begin article-title 65
Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes
###end article-title 65
###begin article-title 66
###xml 71 93 71 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 71 92 <span type="species:ncbi:5833">Plasmodium falciparum</span>
A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites
###end article-title 66
###begin article-title 67
Invasion of red blood cells by malaria parasites
###end article-title 67
###begin article-title 68
###xml 78 89 78 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites
###end article-title 68
###begin article-title 69
###xml 40 50 40 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium</italic>
Targeting nutrient uptake mechanisms in Plasmodium
###end article-title 69
###begin article-title 70
Deciphering the export pathway of malaria surface proteins
###end article-title 70
###begin article-title 71
###xml 16 38 16 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 16 37 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Interactions of Plasmodium falciparum erythrocyte membrane protein 3 with the red blood cell membrane skeleton
###end article-title 71
###begin article-title 72
###xml 57 79 57 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 57 78 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Structural and functional studies of interaction between Plasmodium falciparum knob-associated histidine-rich protein (KAHRP) and erythrocyte spectrin
###end article-title 72
###begin article-title 73
###xml 56 78 56 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 56 77 <span type="species:ncbi:5833">Plasmodium falciparum</span>
The ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum stabilizes spectrin tetramers and suppresses further invasion
###end article-title 73
###begin article-title 74
###xml 54 75 54 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 54 75 <span type="species:ncbi:5833">Plasmodium falciparum</span>
A protein interaction network of the malaria parasite Plasmodium falciparum
###end article-title 74
###begin article-title 75
PlasmoDB
###end article-title 75
###begin article-title 76
DAVID
###end article-title 76
###begin article-title 77
GeneCards
###end article-title 77
###begin article-title 78
Entrez Gene
###end article-title 78
###begin article-title 79
GeneDB
###end article-title 79
###begin article-title 80
###xml 43 48 <span type="species:ncbi:4932">yeast</span>
Rapid and reliable protein extraction from yeast
###end article-title 80
###begin article-title 81
High-throughput two-hybrid analysis. The promise and the peril
###end article-title 81
###begin article-title 82
###xml 67 78 67 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
A gene-family encoding small exported proteins is conserved across Plasmodium genus
###end article-title 82
###begin article-title 83
###xml 15 37 15 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 15 36 <span type="species:ncbi:5833">Plasmodium falciparum</span>
etramps, a new Plasmodium falciparum gene family coding for developmentally regulated and highly charged membrane proteins located at the parasite-host cell interface
###end article-title 83
###begin article-title 84
###xml 25 47 25 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 25 46 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Reliable transfection of Plasmodium falciparum using non-commercial plasmid mini preparations
###end article-title 84
###begin article-title 85
###xml 93 98 <span type="species:ncbi:9606">human</span>
Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins
###end article-title 85
###begin article-title 86
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms
###end article-title 86
###begin article-title 87
Common apolipoprotein E polymorphisms and risk of clinical malaria in the Gambia
###end article-title 87
###begin article-title 88
Does apolipoprotein E polymorphism influence susceptibility to malaria?
###end article-title 88
###begin article-title 89
Apolipoprotein E polymorphisms and risk of malaria
###end article-title 89
###begin article-title 90
###xml 66 87 66 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 66 87 <span type="species:ncbi:5833">Plasmodium falciparum</span>
The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum
###end article-title 90
###begin article-title 91
Discovery of gene function by expression profiling of the malaria parasite life cycle
###end article-title 91
###begin article-title 92
Phobius
###end article-title 92
###begin article-title 93
Proteomics approach reveals novel proteins on the surface of malaria-infected erythrocytes
###end article-title 93
###begin article-title 94
###xml 24 46 24 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 24 45 <span type="species:ncbi:5833">Plasmodium falciparum</span>
A proteomic view of the Plasmodium falciparum life cycle
###end article-title 94
###begin article-title 95
###xml 39 61 39 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 39 60 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Characterization of antigen-expressing Plasmodium falciparum cDNA clones that are reactive with parasite inhibitory antibodies
###end article-title 95
###begin article-title 96
L-FABP is a critical host factor for successful malaria liver stage development
###end article-title 96
###begin article-title 97
###xml 21 32 21 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
Genetically modified Plasmodium parasites as a protective experimental malaria vaccine
###end article-title 97
###begin article-title 98
Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites
###end article-title 98
###begin article-title 99
Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes
###end article-title 99
###begin article-title 100
Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?
###end article-title 100
###begin article-title 101
High frequency of the apolipoprotein E *4 allele in African pygmies and most of the African populations in sub-Saharan Africa
###end article-title 101
###begin article-title 102
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Toxoplasma gondii </italic>
###xml 0 17 <span type="species:ncbi:5811">Toxoplasma gondii</span>
Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space
###end article-title 102
###begin article-title 103
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Toxoplasma gondii </italic>
###xml 0 17 <span type="species:ncbi:5811">Toxoplasma gondii</span>
Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition
###end article-title 103
###begin article-title 104
###xml 91 101 91 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Toxoplasma</italic>
Peculiarities of host cholesterol transport to the unique intracellular vacuole containing Toxoplasma
###end article-title 104
###begin article-title 105
A malaria protein exported into a new compartment within the host erythrocyte
###end article-title 105
###begin article-title 106
Organization of ETRAMPs and EXP-1 at the parasite-host cell interface of malaria parasites
###end article-title 106
###begin article-title 107
Trafficking and developmental signaling: Alix at the crossroads
###end article-title 107
###begin article-title 108
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
How HIV-1 hijacks ALIX
###end article-title 108
###begin article-title 109
In-depth analysis of the membrane and cytosolic proteome of red blood cells
###end article-title 109
###begin article-title 110
MAVID
###end article-title 110

